MedTrace Logo

International Registry for ASD Closure by Using the Occlutech®Flex II Device in More Than 2000 Patients

NCT02766569 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2016-09-09

No results posted yet for this study

Summary

The IRFACODE II study will evaluate the performance and safety of the Occlutech® Flex II device in patients with closure of secundum atrial septal defects (ASD II).

Conditions

  • Atrial Septal Defect

Interventions

DEVICE

ASD closure with the Occlutech Flex II ASD closure device

Monitoring of possible device related side effects with a minumum of 1 year follow-up.

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Nikolaus A Haas, MD, PhD · Ludwig-Maximilians - University of Munich

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-07-31
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02766569 on ClinicalTrials.gov